Citation: Gr. Tennvall et J. Apelqvist, Prevention of diabetes-related foot ulcers and amputations: a cost-utilityanalysis based on Markov model simulations, DIABETOLOG, 44(11), 2001, pp. 2077-2087
Citation: Gr. Tennvall et J. Apelqvist, Health-related quality of life in patients with diabetes mellitus and footulcers, J DIABET C, 14(5), 2000, pp. 235-241
Citation: Gr. Tennvall et al., The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish Inpatient Registry with the consequences for cost estimations, J INTERN M, 248(5), 2000, pp. 397-405
Citation: Gr. Tennvall et al., Cost effectiveness of Helicobacter pylori eradication therapies in patients with duodenal ulcer - An analysis of triple therapy versus two dual therapy alternatives, PHARMACOECO, 16(3), 1999, pp. 297-306
Citation: Gr. Tennvall et Jo. Fernberg, Economic evaluation of gemcitabine single agent therapy compared with standard treatment in stage IIIB and IV non-small cell lung cancer, MED ONCOL, 15(2), 1998, pp. 129-136